A federal appeals court has reinstated a class action against drugmakers by consumers alleging economic losses due to the packaging of eye medication.
In a 2-1 decision on Wednesday, the U.S. Court of Appeals for the 3rd Circuit said the trial court had erred in dismissing the plaintiffs’ case for standing, applying too narrow of a definition of consumer protection statutes.
To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2ioi0Hq